Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten L Simoons

Showing results (171-180 of 185) with videos related to

Pageof 19
Sort By:
European Heart Journal|May 8, 2014
Risk stratification for sudden cardiac death: current status and challenges for the futureHein J J Wellens, Peter J Schwartz, Fred W Lindemans, et al.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Systematic adjudication of myocardial infarction end-points in an international clinical trialKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Journal of Hypertension|December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsJasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
Circulation|August 28, 2012
Third universal definition of myocardial infarctionKristian Thygesen, Joseph S Alpert, Allan S Jaffe, et al.
Circulation|December 29, 2018
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary SyndromeRohit M Oemrawsingh, K Martijn Akkerhuis, Maarten de Mulder, et al.
BMJ Open|December 25, 2016
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the NetherlandsRohit M Oemrawsingh, K Martijn Akkerhuis, Victor A Umans, et al.
European Heart Journal|August 28, 2012
Third universal definition of myocardial infarctionKristian Thygesen, Joseph S Alpert, Allan S Jaffe, et al.
European Journal of Human Genetics : EJHG|June 12, 2014
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approachJorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
Pageof 19

Showing results (171-180 of 185) with videos related to

Sort By:
Pageof 19
European Heart Journal|May 8, 2014
Risk stratification for sudden cardiac death: current status and challenges for the futureHein J J Wellens, Peter J Schwartz, Fred W Lindemans, et al.
European Heart Journal|June 12, 2010
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery diseaseJasper Jan Brugts, Aaron Isaacs, Eric Boersma, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Systematic adjudication of myocardial infarction end-points in an international clinical trialKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT studyKenneth W Mahaffey, Robert A Harrington, Martijn Akkerhuis, et al.
Journal of Hypertension|December 16, 2010
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individualsJasper J Brugts, Aaron Isaacs, Moniek Pm de Maat, et al.
Circulation|August 28, 2012
Third universal definition of myocardial infarctionKristian Thygesen, Joseph S Alpert, Allan S Jaffe, et al.
Circulation|December 29, 2018
High-Frequency Biomarker Measurements of Troponin, NT-proBNP, and C-Reactive Protein for Prediction of New Coronary Events After Acute Coronary SyndromeRohit M Oemrawsingh, K Martijn Akkerhuis, Maarten de Mulder, et al.
BMJ Open|December 25, 2016
Cohort profile of BIOMArCS: the BIOMarker study to identify the Acute risk of a Coronary Syndrome-a prospective multicentre biomarker study conducted in the NetherlandsRohit M Oemrawsingh, K Martijn Akkerhuis, Victor A Umans, et al.
European Heart Journal|August 28, 2012
Third universal definition of myocardial infarctionKristian Thygesen, Joseph S Alpert, Allan S Jaffe, et al.
European Journal of Human Genetics : EJHG|June 12, 2014
Identifying genetic risk variants for coronary heart disease in familial hypercholesterolemia: an extreme genetics approachJorie Versmissen, Daniëlla M Oosterveer, Mojgan Yazdanpanah, et al.
Pageof 19